入院时的高血糖与预后不良密切相关，早期干预可以改善 COVID-19 患者的结局。
At-admission hyperglycemia is consistently associated with poor prognosis and early intervention can improve outcomes in patients with COVID-19.
机构信息
Department of Diabetes & Endocrinology, G.D Hospital & Diabetes Institute, Kolkata, India.
出版信息
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1641-1644. doi: 10.1016/j.dsx.2020.08.034. Epub 2020 Aug 29.
Abstract
BACKGROUND & AIMS: At-admission hyperglycemia have been associated with poorer outcome during critical illnesses. At-admission hyperglycemia in previously unknown diabetes is not uncommonly encountered entity in patients with COVID-19. We sought to find out the outcomes of at-admission hyperglycemia and effect of early intervention to achieve optimal glycemic control in relation to COVID-19 patients.
METHODS
We searched the PubMed and Google Scholar database up till August 20, 2020 using specific keywords related to our aims and objectives.
RESULTS
All currently available evidences clearly hint that at-admission hyperglycemia in patients with COVID-19 is associated with a poorer outcome, compared with normoglycemic individuals. Fortunately, early intervention by achieving an optimal glycemic control has also been associated with a significant improvement in the outcomes in patients with COVID-19.
CONCLUSION
At-admission hyperglycemia should be taken seriously by all clinicians treating patients with COVID-19. All efforts should be made towards an optimal glycemic control in patients with COVID-19, even in absence of pre-existing diabetes.
摘要
背景与目的
入院时的高血糖与危重疾病期间的不良预后相关。在 COVID-19 患者中，以前未确诊的糖尿病患者中常见入院时高血糖。我们试图了解入院时高血糖的结果，以及早期干预以实现最佳血糖控制对 COVID-19 患者的影响。
方法
我们使用与目标相关的特定关键字，在 2020 年 8 月 20 日之前搜索了 PubMed 和 Google Scholar 数据库。
结果
所有现有证据清楚地表明，与血糖正常的个体相比，COVID-19 患者的入院时高血糖与较差的预后相关。幸运的是，通过实现最佳血糖控制进行早期干预也与 COVID-19 患者的结局显著改善相关。
结论
治疗 COVID-19 患者的所有临床医生都应认真对待入院时的高血糖。应尽一切努力使 COVID-19 患者的血糖控制达到最佳，即使在没有预先存在的糖尿病的情况下也是如此。
相似文献
1
At-admission hyperglycemia is consistently associated with poor prognosis and early intervention can improve outcomes in patients with COVID-19.入院时的高血糖与预后不良密切相关，早期干预可以改善 COVID-19 患者的结局。
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1641-1644. doi: 10.1016/j.dsx.2020.08.034. Epub 2020 Aug 29.
2
Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19.高血糖而无糖尿病和新发糖尿病均与 COVID-19 的预后不良相关。
Diabetes Res Clin Pract. 2020 Sep;167:108382. doi: 10.1016/j.diabres.2020.108382. Epub 2020 Aug 25.
3
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.新诊断的糖尿病和入院时的高血糖通过加重呼吸恶化预测 COVID-19 的严重程度。
Diabetes Res Clin Pract. 2020 Oct;168:108374. doi: 10.1016/j.diabres.2020.108374. Epub 2020 Aug 15.
4
Prognostic Value of Hyperglycemia and Insulin Resistance Among Patients with Confirmed COVID-19 Infections at Admission to the Alexandria Fever Hospital, Egypt.埃及亚历山大热病医院收治的确诊新型冠状病毒肺炎感染患者中高血糖和胰岛素抵抗的预后价值
Metab Syndr Relat Disord. 2024 Sep;22(7):551-557. doi: 10.1089/met.2024.0066. Epub 2024 Apr 29.
5
Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19?血糖控制不佳会增加糖尿病合并新冠病毒肺炎患者的病情严重程度及死亡率吗？
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):725-727. doi: 10.1016/j.dsx.2020.05.037. Epub 2020 May 27.
6
Blood glucose levels should be considered as a new vital sign indicative of prognosis during hospitalization.血糖水平应被视为一种新的生命体征，可用于提示住院期间的预后。
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):221-227. doi: 10.1016/j.dsx.2020.12.032. Epub 2021 Jan 2.
7
Hyperglycaemia increases mortality risk in non-diabetic patients with COVID-19 even more than in diabetic patients.高血糖使非糖尿病 COVID-19 患者的死亡风险比糖尿病患者更高。
Endocrinol Diabetes Metab. 2021 Oct;4(4):e00291. doi: 10.1002/edm2.291. Epub 2021 Jul 18.
8
Clinical Features of COVID-19 Patients with Diabetes and Secondary Hyperglycemia.COVID-19 患者伴发糖尿病与高血糖的临床特征。
J Diabetes Res. 2020 Aug 24;2020:3918723. doi: 10.1155/2020/3918723. eCollection 2020.
9
Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes.新诊断的糖尿病与 COVID-19 入院时的既有糖尿病：相关因素、短期结局和长期血糖表型。
J Diabetes Complications. 2022 Apr;36(4):108145. doi: 10.1016/j.jdiacomp.2022.108145. Epub 2022 Feb 4.
10
Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019.空腹血糖受损和糖尿病与 2019 冠状病毒病患者的并发症和死亡率升高相关。
Front Endocrinol (Lausanne). 2020 Jul 10;11:525. doi: 10.3389/fendo.2020.00525. eCollection 2020.
引用本文的文献
1
Long-term outcome of patients with diabetic-range hyperglycemia first detected during admission for COVID-19: A single-center observational study.2019冠状病毒病住院期间首次检测到的糖尿病范围高血糖患者的长期结局：一项单中心观察性研究
J Family Med Prim Care. 2024 Aug;13(8):3374-3380. doi: 10.4103/jfmpc.jfmpc_140_24. Epub 2024 Jul 26.
2
[Impact of hyperglycemia on the prognosis of patients hospitalized for severe pneumonia in COVID-19].[高血糖对新型冠状病毒肺炎合并重症肺炎住院患者预后的影响]
Rev Med Inst Mex Seguro Soc. 2023 May 2;61(3):335-341.
3
Diabetes and SARS-CoV-2 Infection: The Potential Role of Antidiabetic Therapy in the Evolution of COVID-19.糖尿病与新型冠状病毒2型感染：抗糖尿病治疗在2019冠状病毒病演变中的潜在作用
Microorganisms. 2023 Jan 6;11(1):145. doi: 10.3390/microorganisms11010145.
4
Does the Hyperglycemia Impact on COVID-19 Outcomes Depend upon the Presence of Diabetes?-An Observational Study.高血糖对2019冠状病毒病（COVID-19）预后的影响是否取决于糖尿病的存在？一项观察性研究。
Metabolites. 2022 Nov 15;12(11):1116. doi: 10.3390/metabo12111116.
5
MIDO COVID: A digital public health strategy designed to tackle chronic disease and the COVID-19 pandemic in Mexico.MIDO COVID：旨在解决墨西哥慢性病和 COVID-19 大流行问题的数字公共卫生战略。
PLoS One. 2022 Nov 17;17(11):e0277014. doi: 10.1371/journal.pone.0277014. eCollection 2022.
6
Diabetes and COVID-19: The potential role of mTOR.糖尿病与 COVID-19：mTOR 的潜在作用。
Diabetes Res Clin Pract. 2022 Apr;186:109813. doi: 10.1016/j.diabres.2022.109813. Epub 2022 Mar 3.
7
Detrimental effect of diabetes and hypertension on the severity and mortality of COVID-19 infection: A multi-center case-control study from India.糖尿病和高血压对 COVID-19 感染严重程度和死亡率的有害影响：来自印度的一项多中心病例对照研究。
Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102248. doi: 10.1016/j.dsx.2021.102248. Epub 2021 Aug 15.
8
A guidance on diagnosis and management of hyperglycemia at COVID care facilities in India.印度新冠照护设施中高血糖诊断和管理指南。
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):407-413. doi: 10.1016/j.dsx.2021.01.015. Epub 2021 Feb 3.
9
High admission blood glucose independently predicts poor prognosis in COVID-19 patients: A systematic review and dose-response meta-analysis.入院时高血糖独立预测COVID-19患者预后不良：一项系统评价和剂量反应荟萃分析。
Diabetes Res Clin Pract. 2021 Jan;171:108561. doi: 10.1016/j.diabres.2020.108561. Epub 2020 Dec 9.
本文引用的文献
1
Strict glycemic control is needed in times of COVID19 epidemic in India: A Call for action for all physicians.在印度新冠疫情期间需要严格控制血糖：呼吁所有医生采取行动。
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1579-1581. doi: 10.1016/j.dsx.2020.08.003. Epub 2020 Aug 10.
2
Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19.高血糖而无糖尿病和新发糖尿病均与 COVID-19 的预后不良相关。
Diabetes Res Clin Pract. 2020 Sep;167:108382. doi: 10.1016/j.diabres.2020.108382. Epub 2020 Aug 25.
3
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.新诊断的糖尿病和入院时的高血糖通过加重呼吸恶化预测 COVID-19 的严重程度。
Diabetes Res Clin Pract. 2020 Oct;168:108374. doi: 10.1016/j.diabres.2020.108374. Epub 2020 Aug 15.
4
Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study.入院时高血糖与 COVID-19 住院患者预后严重程度相关：比萨 COVID-19 研究。
Diabetes Care. 2020 Oct;43(10):2345-2348. doi: 10.2337/dc20-1380. Epub 2020 Aug 11.
5
Fasting blood glucose predicts the occurrence of critical illness in COVID-19 patients: A multicenter retrospective cohort study.空腹血糖可预测COVID-19患者危重症的发生：一项多中心回顾性队列研究。
J Infect. 2020 Sep;81(3):e20-e23. doi: 10.1016/j.jinf.2020.07.006. Epub 2020 Jul 8.
6
Hyperglycaemia on admission to hospital and COVID-19.入院时的高血糖与新型冠状病毒肺炎
Diabetologia. 2020 Nov;63(11):2486-2487. doi: 10.1007/s00125-020-05216-2. Epub 2020 Jul 6.
7
Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID-19.在糖尿病、糖尿病前期和肥胖症患者中，葡萄糖代谢受损与严重的 COVID-19 相关。
J Med Virol. 2021 Jan;93(1):409-415. doi: 10.1002/jmv.26227. Epub 2020 Jul 17.
8
Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study.血糖水平升高预示 COVID-19 住院患者预后不良：一项回顾性队列研究。
BMJ Open Diabetes Res Care. 2020 Jun;8(1). doi: 10.1136/bmjdrc-2020-001476.
9
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study.COVID-19 合并糖尿病住院患者的表型特征和预后：CORONADO 研究。
Diabetologia. 2020 Aug;63(8):1500-1515. doi: 10.1007/s00125-020-05180-x. Epub 2020 May 29.
10
Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?COVID-19 影响下的高血糖患者结局：我们能否在血糖控制方面做得更好？
Diabetes Care. 2020 Jul;43(7):1408-1415. doi: 10.2337/dc20-0723. Epub 2020 May 19.
Zotero 插件